Novel risk factors for venous thromboembolism.
VTE can be considered as a multicausal disease involving various inherited and acquired prothrombotic conditions. Although greater emphasis has classically been given to traditional thrombophilic risk factors, there is increasing recognition of less typical precipitating conditions and events. In this article, the authors focus on the most promising, persistent, and potentially treatable novel risk factors.
Squizzato
Alessandro
A
Department of Clinical Medicine, University of Insubria, UO Medicina I, Ospedale di Circolo, Varese, Italy. alexsquizzo@libero.it
Brivio
Lorenza
L
Appio
Lorena
L
Dentali
Francesco
F
D002318:Cardiovascular Diseases / Q000150:complications; D002986:Clinical Trials as Topic; D004700:Endocrine System Diseases / Q000150:complications; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics; D009154:Mutation / Q000235:genetics; D009196:Myeloproliferative Disorders / Q000150:complications; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000209:etiology* / Q000473:pathology
C507924:JAK2 protein, human; D053614:Janus Kinase 2